Relay Therapeutics, Inc. (RLAY)
8.03
+0.24
(+3.08%)
USD |
NASDAQ |
Dec 12, 16:00
8.17
+0.14
(+1.74%)
After-Hours: 20:00
Relay Therapeutics Shareholders Equity (Quarterly): 607.71M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Lantheus Holdings, Inc. | 1.119B |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Arrowhead Pharmaceuticals, Inc. | 466.05M |
| Insmed, Inc. | 945.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 670.00M |
| Total Liabilities (Quarterly) | 62.29M |
| Debt to Equity Ratio | 0.0548 |
| Current Ratio | 19.14 |
| Net Debt Paydown Yield | 0.39% |